- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma in Poland
Total 473 results
-
BioAtla, Inc.RecruitingHead and Neck Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States
-
Rakuten Medical, Inc.Active, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head-and-neck Squamous-cell Carcinoma | Metastatic Cutaneous Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell CarcinomaUnited States
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Maria Sklodowska-Curie National Research Institute...Centre of Postgraduate Medical EducationCompletedSquamous Cell Carcinoma of the Head and Neck | Esophageal Squamous Cell CarcinomaPoland
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research InstituteActive, not recruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Exicure, Inc.TerminatedAdvanced or Metastatic Solid Tumors | Advanced or Metastatic Merkel Cell Carcinoma | Advanced or Metastatic Cutaneous Squamous Cell Carcinoma | Advanced or Metastatic Melanoma | Advanced or Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research InstituteRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Incyte Biosciences International SàrlWithdrawnRecurrent Head and Neck Squamous Cell Carcinoma | Advanced Malignancies | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Providence Health & ServicesBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
Providence Health & ServicesMedImmune LLC; Providence Cancer Center, Earle A. Chiles Research InstituteActive, not recruitingMelanoma | Head and Neck Cancer | Carcinoma, Squamous Cell | Head and Neck Squamous Cell Carcinoma | Cell Cancer, SquamousUnited States
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Korea, Republic of, United Kingdom, Spain, Belgium, Singapore, Canada, Netherlands, Australia
-
EMD SeronoCompletedSquamous Cell Carcinoma of the Head and Neck CancerCzech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
PCI Biotech ASTerminatedRecurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and NeckGermany, United Kingdom, France, Lithuania, Netherlands, Poland
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research InstituteWithdrawnMetastatic Melanoma | Head and Neck Squamous Cell CarcinomaUnited States
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingHead and Neck CancerCanada, Spain, Korea, Republic of, United States, Austria, Japan, United Kingdom, Taiwan, Italy, Hungary, Australia, Turkey, Poland, Portugal
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; IO BiotechRecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
MacroGenicsTerminatedHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck Squamous Cell CarcinomaSpain, United States, Australia, Poland, Ukraine, Bulgaria, Hungary
-
Leiden University Medical CenterHollandPTCTerminatedSquamous Cell Carcinoma of the Head and NeckNetherlands
-
National Cancer Institute (NCI)RecruitingRecurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IV Hypopharyngeal... and other conditionsUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galecto Biotech... and other collaboratorsRecruitingMetastatic Melanoma | Head and Neck Squamous Cell CarcinomaUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
RTOG Foundation, Inc.Bristol-Myers SquibbCompletedHead and Neck Squamous Cell Carcinoma (HNSCC)United States
-
GenmabTerminatedHead and Neck Cancer | Squamous Cell CancerBelgium, Sweden, United States, France, Netherlands
-
Joris B.W. ElbersErasmus Medical Center; HollandPTCRecruitingHead and Neck Squamous Cell Carcinoma | Radiotherapy | Proton Therapy | Hypofractionation | Immune System SuppressionNetherlands
-
GenmabBioNTech SERecruitingMelanoma | Malignant Solid Tumor | Non Small Cell Lung Cancer (NSCLC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Colorectal Cancer (CRC)United States, Taiwan, Spain, Israel, Korea, Republic of, France, Italy, Denmark, Germany, United Kingdom, Georgia, Moldova, Republic of
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
Presage BiosciencesAstraZenecaRecruitingHead and Neck Squamous Cell CarcinomaUnited States
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
Dynavax Technologies CorporationMerck Sharp & Dohme LLCTerminatedMetastatic Melanoma | Head Neck CancerUnited States, Germany, New Zealand, Australia
-
Erasmus Medical CenterRecruitingSquamous Cell Carcinoma of the Head and Neck | Oral Cancer | Squamous Cell Carcinoma of the Oral CavityNetherlands
-
Bristol-Myers SquibbCompletedHead and Neck CancerUnited States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
Boehringer IngelheimActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Spain, United States, United Kingdom, France, Thailand, Malaysia, Mexico, Romania, Poland, Japan, Moldova, Republic of
-
Replimune Inc.Bristol-Myers SquibbWithdrawnSquamous Cell Carcinoma of Head and Neck | Recurrent Head and Neck Squamous Cell Carcinoma | Locally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, United Kingdom, Czechia, France, Germany, Greece, Poland
-
BayerCompletedHepatocellular Carcinoma (HCC) | Non-small Cell Lung Cancer (NSCLC) | Head and Neck Squamous Cell Carcinoma (HNSCC)United States, Canada
-
AbbVieIdera Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors CancerUnited States, France, Germany, Israel, Netherlands, Spain
-
AstraZenecaRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, Korea, Republic of, United Kingdom, Germany, Vietnam, Japan, France, India, Taiwan, Thailand, Malaysia, Turkey, Brazil, Belgium, Poland, Austria, Hungary
-
OHSU Knight Cancer InstituteOregon Health and Science University; Cambia Health FoundationRecruitingHead and Neck Squamous Cell Carcinoma | Malignant Head and Neck NeoplasmUnited States
-
Amsterdam UMC, location VUmcBristol-Myers SquibbActive, not recruitingOral Cavity Squamous Cell CarcinomaNetherlands
-
GenmabCompletedHead and Neck Cancer | Squamous Cell CancerSweden, United Kingdom, France, Hungary, Canada, Brazil, Belgium, Lithuania, Russian Federation, Serbia, Estonia, Poland
-
SanofiGroupe Oncologie Radiotherapie Tete et CouCompletedHead and Neck Squamous Cell CarcinomaUnited States, France, Canada, Poland, Germany, Spain, Switzerland, Singapore, Taiwan, Argentina, Hungary, Italy, Chile, Hong Kong, South Africa, Australia, New Zealand
-
Neogene Therapeutics, Inc.RecruitingBreast Cancer | Pancreatic Adenocarcinoma | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Colorectal Carcinoma | Other Solid TumorsUnited States
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbActive, not recruitingOropharynx Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States
-
GlaxoSmithKlineNot yet recruitingNeoplasms, Head and NeckUnited States, Taiwan, Mexico, Belgium, Sweden, Australia, Germany, Canada, Japan, Norway, Portugal, Turkey, United Kingdom, Korea, Republic of, Argentina, Italy, Poland, Romania, Czechia, Hungary, Brazil, France, Greece
-
Glycotope GmbHCompletedCetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer (RESGEX)Carcinoma, Squamous Cell of Head and NeckBelgium, France, Germany, Italy, Poland, Romania, Spain